ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

University of Glasgow at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

University of Glasgow brings 5 presentations to ACR Convergence 2026 in Orlando. Its program centres on psoriatic arthritis, covering head-to-head treatment comparison, minimal disease activity with guselkumab and IL-17 inhibitors, and protein and biomarker profiling of treatment response.

OrganizationACR Convergence 2026 Attendance
Universities and research institutes
Public research university in Scotland.
Industry
Sun Nov 8
10:30am–11:15am
A Bold Step Forward: BE BOLD — A Head-to-Head Superiority Trial in PsA
Innovation Theater A
Spondyloarthritis and PsA · Offered by UCB

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Glasgow

Tell us what you sell and we’ll find the people at University of Glasgow most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction